Icon

EOHILIA (NDA213976)- (2MG/10ML)

BUDESONIDE TAKEDA PHARMS USA
2MG/10ML
No Yes
2039-Jan-10 Expired
None 2027-Feb-09
None No
EOHILIA is a corticosteroid indicated for 12 weeks of treatment in adult and pediatric patients 11 years of age and older with eosinophilic esophagitis (EoE).
0 0 0
Total Other Developers 3
Drugs with Suitability No
2MG/10ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.